English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | Dec 9, 2025

Prehabilitation reduces post-surgery disability in frail older adults if fully completed

Patient Daily | Dec 9, 2025

MIT develops noninvasive blood-glucose monitor aiming to replace finger-prick tests

Patient Daily | Dec 9, 2025

Turnover continues among top FDA officials amid growing regulatory uncertainty

Patient Daily | Dec 9, 2025

Lilly and Novo Nordisk drug pricing changes open market opportunities for rivals

Patient Daily | Dec 9, 2025

Penn Medicine appoints new leaders aiming to reshape undergraduate and graduate medical education

Patient Daily | Dec 9, 2025

Prasad memo prompts debate as FDA sees leadership changes and new drug data emerges

Patient Daily | Dec 9, 2025

Bristol Myers Squibb postpones Alzheimer’s psychosis drug trial results after site irregularities

Patient Daily | Dec 9, 2025

UTHealth Houston researchers secure nearly $10 million for diverse state-backed cancer initiatives

Trending

+ Regulatory
B. D. Benavides | Mar 18, 2026

Taxpayer advocate: Instead of improving product safety, litigation can result in the ‘opposite because runaway legal costs deter innovation'

+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal

+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'

+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug

  • « First
  • «
  • …
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily